4987 -- Pharmaceutical Investment Oversight and Accountability Act | Poliscope

Pharmaceutical Investment Oversight and Accountability Act

4987

119th Congress

Health

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

July 15, 2026

Latest Action

July 15, 2026

Primary Sponsor

Elizabeth WarrenDemocratic(MA)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

0pct

0d open

vs 5,674 other S bills in the 119th — cohort avg 32d

Summary

No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.

Actions (2)

July 15, 2026

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

July 15, 2026

Introduced in Senate

Committees

Committee	Chamber	Activity	Date
Banking, Housing, and Urban Affairs Committee	Senate	Referred To	July 15, 2026

Text Versions

Version	Date	Links
Introduced in Senate	July 15, 2026	XML

Cosponsors (2)

Name	Party	State
Kirsten E. Gillibrand	Democratic	NY
Rick Scott	Republican	FL

Similar Bills (AI)

Bills with similar content found using semantic analysis.

2939

118th

85%

Pharmacy Access Oversight and Reporting Act

2658

119th

80%

Medication Affordability and Patent Integrity Act

198

118th

80%

Drug Pricing Transparency and Accountability Act

2454

Sources: Congress.gov